People who consumed THC were more likely to recall words that were never shown to them.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new...
The study found that 88% of participating officers knew little or nothing about the regulations before taking part in the training.
The authors say the guidance aims to address "clear gaps" in prescriber training and education.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively...
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the...
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line...
A quick rundown of the highlights so far, and what’s still left to look forward to.
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also...
The event brought together expert medical and scientific voices and powerful patient perspectives.
